Altamira Therapeutics Ltdis A Preclinical Stagebiopharmaceutical Company Based In Hamiltonbermudawith Operations In Switzerland And Australiathecompanyformerly Known As Auris Medical Holding Ltd Focuses On Rna Based Therapeutics And Peptidebased Nanoparticledelivery Technologiesaltamira Specializes In Developing Rna Delivery Platforms For Non Liver Tissues Using Its Proprietary Xphorea Coligophorea Cand Semaphorea C Nanoparticlesystemstheseplatforms Facilitatethetargeted Delivery Of Rna Payloadssuch As Sirna And Circular Rnafor Various Therapeutic Applicationsthecompany Is Advancing Several Programsincluding Am 401 For Kras Driven Cancers And Am 411 For Rheumatoid Arthritisboth In Thepreclinical Stageadditionallyaltamira Is Working On A Drug Freenasal Spraybentrioa Aimed At Protecting Against Airborneallergens And Virusesthecompany Is Shifting Its Focus Towards Rna Therapeutics Whiledivesting From Legacy Assets In Allergology And Viral Infectionsaltamira Actively Collaborates With Organizations To Enhanceits Rna Delivery Capabilities And Has Achieved Recent Milestones In Its Development Efforts
